La cadena de opciones muestra datos clave de las opciones de acciones de iHuman a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para iHuman..

iHuman (NYSE:IH) Bolsa, Cadena de Opciones

iHuman

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

TSLA

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este jueves: TSLA, IH, ADD, HIT y TM.

5 acciones en el foco este jueves: TSLA, IH, ADD, HIT y TM

iHuman Inc. American depositary shares, each representing five Class A ordinary shares

iHuman Inc

INNOVATIVE HLDGS ALL INC by Innovative Holdings Alliance,Inc.

Innovative Holdings Alliance Inc

iShares Cybersecurity and Tech ETF

Inchcape PLC

Voya Emerging Markets High Income Dividend Equity Fund Common Shares

Voya Emerging Markets High Dividend Equity Fund

WisdomTree International Hedged Quality Dividend Growth Fund

iShares U.S. Pharmaceutical ETF

iHeartMedia Inc

iShares U.S. Health Care Providers ETF

Invictus Hyperion Fund

Intercontinental Hotels Group American Depositary Shares (Each representing one Ordinary Share)

InterContinental Hotels Group PLC

INTERACT HLDGS GROUP INC by Interact Holdings Group, Inc.

Jun An Kang Group Inc

IHH HEALTHCARE BHD ORD by IHH Healthcare BHD

IHH Healthcare Bhd

iShares U.S. Medical Devices ETF

IHI Corp

ISHARES III IRE USD ORD by Ishares III Plc

ISHARES II PLC EU 50 UCIT by iShares II plc.

Invesco High Income 2023 Target Term Fund Com

IMMUTABLE HLDGS SUB VT SH by Immutable Holdings Inc.

Immutable Holdings Inc

INTL BETHLEHEM MNG by International Bethlehem Mining Corp.

Incannex Healthcare Ltd

INTEGRAFIN HLDGS PLC by INTEGRAFIN HLDGS PLC

IntegraFin Holdings PLC

ISHARES MSCI EURO EX-UK by IShares Plc.

IHS Holding Ltd

INTL HOUSEWARES RET ORD by INTERNATIONAL HOUSEWARES RETAIL CO LTD

International Housewares Retail Co Ltd

InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust

Invesco High Income 2024 Target Term Fund Com

INTEGRATIVE HLTH TCHS INC by Integrative Health Technologies, Inc.

Integrative Health Technologies Inc

VanEck International High Yield Bond ETF

Invesco High Yield Bond Factor ETF

<h3>Gainers</h3>
<ul>
<li>Token Cat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TC#NASDAQ">TC</a>) shares rose 13.3% to $0.85 during Thursday's pre-market session. The company's market cap stands at $2.6 million. </li>
<li>TruGolf Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) shares rose 10.16% to $0.26. The company's market cap stands at $11.4 million. </li>
<li>Ibotta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>) shares increased by 7.28% to $53.78. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONE#NASDAQ">UONE</a>) shares moved upwards by 7.22% to $1.78. The company's market cap stands at $85.2 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Intelligent Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTJ#NASDAQ">INTJ</a>) shares rose 6.71% to $0.64. The market value of their outstanding shares is at $8.4 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) shares moved upwards by 6.63% to $0.62. The company's market cap stands at $6.1 million. As per the press release, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) stock fell 16.8% to $0.63 during Thursday's pre-market session. The company's market cap stands at $16.5 million. </li>
<li>Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) shares fell 14.78% to $1.9. The company's market cap stands at $246.7 million. </li>
<li>HWH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) stock fell 12.36% to $1.56. The company's market cap stands at $10.1 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) stock fell 11.89% to $0.81. The company's market cap stands at $7.7 million. </li>
<li>NextPlat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPL#NASDAQ">NXPL</a>) shares declined by 9.38% to $0.58. The market value of their outstanding shares is at $15.0 million. As per the press release, Q1 earnings came out today. </li>
<li>Antelope Ent Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares decreased by 7.5% to $2.47. The market value of their outstanding shares is at $8.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AEHL

IBTA

INTJ

MITQ

NXPL

SEAT

TNMG

TRUG

UONE

VSME

12 Communication Services Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares increased by 85.4% to $0.84 during Thursday's pre-market session. The company's market cap stands at $20.8 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares moved upwards by 43.64% to $0.05. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) shares rose 40.74% to $1.9. The market value of their outstanding shares is at $11.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock rose 35.69% to $0.22. The company's market cap stands at $11.6 million. </li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) stock rose 22.33% to $8.6. The company's market cap stands at $377.4 million. </li>
<li>Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) stock increased by 20.25% to $2.85. The company's market cap stands at $250.1 million. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock fell 82.1% to $0.04 during Thursday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock declined by 37.35% to $0.18. The market value of their outstanding shares is at $5.1 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock fell 24.51% to $0.17. The market value of their outstanding shares is at $24.1 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>IN8bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) shares declined by 20.66% to $0.12. The company's market cap stands at $10.5 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) stock declined by 20.16% to $3.05. The company's market cap stands at $2.5 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares decreased by 16.96% to $0.69. The company's market cap stands at $83.2 million. As per the press release, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AYTU

BDSX

EKSO

HCTI

INAB

IVVD

KLTO

NAOV

NCNA

NNNN

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares rose 226.7% to $0.91 during Thursday's pre-market session. The market value of their outstanding shares is at $28.9 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock increased by 115.56% to $0.21. The company's market cap stands at $30.6 million. </li>
<li>Innovative Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISSC#NASDAQ">ISSC</a>) stock rose 27.39% to $9.36. The market value of their outstanding shares is at $164.2 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>NV5 Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>) shares rose 16.65% to $21.99. The company's market cap stands at $1.4 billion. </li>
<li>Acuren (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TIC#AMEX">TIC</a>) stock moved upwards by 13.43% to $11.99. The company's market cap stands at $1.4 billion. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares moved upwards by 9.33% to $0.43. The market value of their outstanding shares is at $5.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) shares fell 29.3% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $18.5 million. </li>
<li>High-Trend International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock decreased by 19.13% to $0.32. The market value of their outstanding shares is at $39.1 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) stock decreased by 16.69% to $5.09. The market value of their outstanding shares is at $850.9 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares decreased by 14.02% to $0.22. The company's market cap stands at $4.6 million. </li>
<li>T1 Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TE#NYSE">TE</a>) shares declined by 13.55% to $1.34. The company's market cap stands at $188.0 million. As per the news, the Q1 earnings report came out today. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock fell 10.89% to $0.25. The company's market cap stands at $7.4 million. As per the press release, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

HTCO

ISSC

NVEE

PGHL

SHLS

UGRO

WATT

WLGS

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) stock moved upwards by 15.1% to $0.91 during Thursday's pre-market session. The company's market cap stands at $171.2 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock increased by 11.37% to $1.57. The company's market cap stands at $9.6 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 10.31% to $1.14. The market value of their outstanding shares is at $8.0 million. </li>
<li>MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) shares moved upwards by 6.84% to $3.9. The company's market cap stands at $140.6 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) shares rose 6.48% to $4.6. The company's market cap stands at $95.6 million. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) shares moved upwards by 6.08% to $0.42. The market value of their outstanding shares is at $39.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares fell 20.6% to $2.08 during Thursday's pre-market session. The company's market cap stands at $125.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock declined by 18.04% to $1.5. </li>
<li>DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) stock fell 13.95% to $14.25. The company's market cap stands at $2.5 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock fell 12.64% to $5.81. The company's market cap stands at $525.8 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock decreased by 9.81% to $0.92. The company's market cap stands at $96.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) stock fell 9.32% to $0.55. The company's market cap stands at $10.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MOVE

NVNI

RCAT

REKR

SGMA

SMRT

SVRE

UBXG

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Synergy CHC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNYR#NASDAQ">SNYR</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. The company reported quarterly sales of $8.17 million.

Earnings

Earnings Beats

SNYR

Synergy CHC Q1 EPS $0.10 Beats $0.07 Estimate, Sales $8.17M Lower Than $9.41M YoY

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) with a Buy and lowers the price target from $13 to $12.

Price Target

Analyst Ratings

Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12

Biotech

General

IMNN

IMUNON Announces Six-Month Data From Phase 1 Proof-Of-Concept Trial Of Its IMNN-101 NA Vaccine Platform; Says Its PlaCCine Platform 'demonstrates better durability and other advantages compared to mRNA vaccines'

Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) announced on Wednesday that it has been chosen by <a href="https://www.benzinga.com/pressreleases/25/05/b45420724/rocket-lab-to-launch-nasa-astrophysics-science-mission-on-electron-to-study-galaxy-evolution" target="_blank" rel="noreferrer noopener">NASA </a><a href="https://www.benzinga.com/pressreleases/25/05/b45420724/rocket-lab-to-launch-nasa-astrophysics-science-mission-on-electron-to-study-galaxy-evolution" target="_blank" rel="noreferrer noopener">to launch its Aspera mission</a>.
Aspera is an astrophysics science mission designed to study the formation and evolution of galaxies and provide new insights into how the universe works.
NASA selected Rocket Lab to launch its Aspera astrophysics mission (studying galaxy formation via UV light) on Electron from Launch Complex 1, targeting no earlier than the first quarter of 2026.
Also Read: <a target="_blank" href="https://www.benzinga.com/content/45012021/rocket-lab-lands-new-contract-builds-momentum-ahead-of-earnings" rel="noreferrer noopener">Rocket Lab Lands New Contract, Builds Momentum Ahead of Earnings</a>
Aspera will utilize a telescope to observe ultraviolet light, studying the hot gas known as the intergalactic medium that exists between galaxies and is believed to play a role in the formation of stars and planets.
This mission will be the first NASA astrophysics endeavor to collect and map these ultraviolet light signatures, potentially revealing deeper insights into the origins of stars, planets, and life in the universe.
Rocket Lab founder and CEO Sir Peter Beck stated, &#8220;As a long trusted launch partner for NASA&#8217;s most pioneering small satellites, it&#8217;s great to be able to continue that support for another innovative science mission like Aspera. Electron has proven itself to be the premier small launcher through complete launch schedule control and reliably accurate orbital deployment, and we&#8217;re looking forward to delivering that again for Aspera.&#8221;
In a separate release, Rocket Lab announced that its Pioneer spacecraft&nbsp;made a successful return to Earth on Wednesday, marking the company&#8217;s second Earth return mission in two months. Varda&#8217;s W-3 mission launched <a target="_blank" href="https://www.benzinga.com/25/05/45414422/rocket-lab-stock-is-rallying-wednesday-whats-going-on" rel="noreferrer noopener">15 days after the return of W-2</a>.
Last week, the company&nbsp;reported financial results for the first quarter, with revenues of $122.57 million, beating the&nbsp;consensus&nbsp;estimate of $121.38 million and loss of 12 cents per share, beating analyst estimates <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45327779/rocket-labs-new-defense-deal-2025-forecast-win-analyst-support" rel="noreferrer noopener">of 13 cents loss per share</a>.
Investors can gain exposure to the stock via&nbsp;ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) and Procure Space ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFO#NASDAQ">UFO</a>).
Price Action: RKLB shares are down 2.40% at $23.55 premarket at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45143330" target="_blank" rel="noreferrer noopener">AI, Hypersonics,&nbsp;$24 Billion&nbsp;Market: Portfolio Manager Gives A Peek Inside GCAD&#8217;s Bet On Drone Warfare Dominance</a></li>
</ul>
Image by Emagnetic via Shutterstock

Equities

Large Cap

Contracts

ARKX

RKLB

Rocket Lab Gets NASA Contract To Launch Aspera Astrophysics Mission

<ul>
<li>Blue Owl Digital Infrastructure Fund III seeks to support the global capital demands of&nbsp;hyperscalers, fueled by ongoing investments in data centers and artificial intelligence.</li>
</ul>
NEW YORK, May 15, 2025 /PRNewswire/ -- Blue Owl Capital Inc. ("Blue Owl") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>), a leading alternative asset manager, announced today the final close of its most recent digital infrastructure fund, Blue Owl Digital Infrastructure Fund III ("ODI III") with $7 billion of total capital commitments. ODI III exceeded the original target of $4 billion and hit its hard cap.
ODI III will focus on developing, acquiring, and owning data centers and other connectivity related real assets to help meet the AI and cloud-driven global digital capacity needs of the world's largest technology companies, with a focus on large-scale, build-to-suit developments.

Blue Owl Closes $7B Digital Infrastructure Fund III To Support Hyperscaler Demand Amid AI And Cloud Boom, Surpassing $4B Target To Invest In Data Centers And Connectivity Assets Worldwide

<a href="https://www.globenewswire.com/Tracker?data=1Cv5vc6xPugdycgEI5g5MdjtOphqPViQBh2de9Wew2xQaCN7hVFga3quhCMOlC-V5wWvMzxJvQZavTaoOXF6bg==">Merus N.V.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) ("Merus", "the Company", "we", or "our"), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics&#xAE;, Triclonics&#xAE; and ADClonics&#xAE;), today announced publication on the mechanism of action of petosemtamab, a bispecific antibody targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G (LGR5), in the scientific journal "Cancers", a MDPI publication, available <a href="https://www.globenewswire.com/Tracker?data=qDy227Jlbf1q1FH5Gxy-pD1yN8G32hMajPBa7ZAAO61n2po-XuClGyspYfkeqMv_Yt_DqAC3_Jcym2YqyszV_3-VsruA190TW6MqqQ6agkc=">here</a>.

MRUS

Merus Announces Publication On Mechanism Of Action Of Petosemtamab, Bispecific Antibody Targeting EGFR And LGR5, In Scientific Journal "Cancers"

WIIM

Youdao shares are trading higher after the company reported a year-over-year increase in Q1 EPS results.

HC Wainwright &amp; Co. analyst Sean Lee reiterates CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) with a Neutral and maintains $1 price target.

Reiteration

CTSO

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

Acuren shares are trading higher after the company announced a merger with NV. Also, the company announced it has been approved for uplisting to the NYSE.

IM Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) reported quarterly earnings of $0.06 per share. This is a 103.23 percent increase over losses of $(1.86) per share from the same period last year. The company reported $8.71 million in sales this quarter. This is a 2.69 percent decrease over sales of $8.95 million the same period last year.

IMCC

IM Cannabis Q1 EPS $0.06 Up From $(1.86) YoY, Sales $8.71M Down From $8.95M YoY

CGNX

IMA E-COMMERCE Enhances Order Fulfillment Efficiency And Sustainability With Cognex's Advanced In-Sight Vision Systems And DataMan Barcode Readers

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>JP Morgan analyst Samik Chatterjee downgraded the rating for Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) from Overweight to Neutral. Luminar shares closed at $4.76 on Wednesday. <a href="https://www.benzinga.com/quote/lazr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank analyst Greg McGinniss downgraded Americold Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) from Sector Outperform to Sector Perform and announced a $20 price target. Americold Realty Trust shares closed at $17.94 on Wednesday. <a href="https://www.benzinga.com/quote/cold/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Daniel Major downgraded the rating for Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) from Buy to Neutral and announced a $31 price target. Alcoa shares closed at $29.61 on Wednesday. <a href="https://www.benzinga.com/quote/aa/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Sami Corwin downgraded the rating for Nkarta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTX#NASDAQ">NKTX</a>) from Outperform to Market Perform. Nkarta shares closed at $1.87 on Wednesday. <a href="https://www.benzinga.com/quote/NKTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group analyst Dana Telsey downgraded Grove Collaborative Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) from Outperform to Market Perform and slashed the price target from $2 to $1.2. Grove Collaborative shares closed at $1.19 on Wednesday. <a href="https://www.benzinga.com/quote/GROV/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying AA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="575" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-1024x575.png" alt="" class="wp-image-916381" style="width:623px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-1024x575.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179.png 1125w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45405004/jim-cramer-sofi-goes-to-new-highs-recommends-not-buying-this-health-care-stock">Jim Cramer: SoFi Goes To &#8216;New Highs,&#8217; Recommends Not Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Downgrades

COLD

GROV

LAZR

NKTX

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Fiscal 2025 Guidance
The Company is updating its expectations for fiscal 2025 revenue to be in the range of $29.0 to $31.0 million. The change in expectations is primarily due to expected continuing disruptions within the U.S. sorghum market due to decreased exports by customers to China and general market uncertainty. In fiscal 2024, comparable revenue from continuing operations was $38.0 million, which excludes revenue generated by the Company's former Australian subsidiary.&nbsp;
The Company now expects Adjusted EBITDA to be in the range of ($8.5) to ($7.0) million for fiscal 2025.

Guidance

SANW

S&W Seed Lowers FY2025 Sales Guidance from $34.50M-$38.00M to $29.00M-$31.00M vs $35.89M Est

Lifeward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) affirms FY2025 sales outlook from $28.00 million-$30.00 million to $28.00 million-$30.00 million vs $28.98 million estimate.

LFWD

Lifeward Affirms FY2025 Sales Guidance of $28.00M-$30.00M vs $28.98M Est

S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.09) by 47.71 percent. This is a 68.16 percent increase over losses of $(1.79) per share from the same period last year. The company reported quarterly sales of $9.55 million which beat the analyst consensus estimate of $9.50 million by 0.53 percent. This is a 1.95 percent increase over sales of $9.37 million the same period last year.

S&W Seed Q3 Adj. EPS $(0.57) Beats $(1.09) Estimate, Sales $9.55M Beat $9.50M Estimate

Rewalk Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.38) by 15.79 percent. This is a 29.03 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $5.03 million which missed the analyst consensus estimate of $5.75 million by 12.51 percent. This is a 4.71 percent decrease over sales of $5.28 million the same period last year.

Earnings Misses

Rewalk Robotics Q1 Adj. EPS $(0.44) Misses $(0.38) Estimate, Sales $5.03M Miss $5.75M Estimate

Press Releases

iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

iHuman Inc. Files 2024 Annual Report on Form 20-F

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

ABBNY

BDOUY

BLTE

BVNRY

CLCGY

CRRFY

DSFIY

EDPFY

EPOAY

FPAFY

ICAGY

IFNNY

KKPNY

MAKSY

PARIS:CA

REPYY

SSEZY

VIOT

Blue Hat Interactive Entertainment Technology - Ordinary Shares

Blue Hat Interactive

DoubleDown Interactive Co., Ltd. - American Depository Shares

DoubleDown Interactive Co

DouYu International Holdings Limited - American Depositary Shares

DouYu Intl Hldgs

Electronic Arts

GCL Global Holdings Ltd - Ordinary Shares

GCL Global Holdings

GDEV

Golden Matrix Group

Gamehaus Holdings Inc. - Class A Ordinary Shares

Gamehaus Holdings

GRAVITY Co., Ltd. - American depositary shares, each representing one common share.

GRAVITY Co

HUYA Inc. American depositary shares, each representing one Class A ordinary share

Comments

iHuman

iHuman (IH) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL